The diversity of KIR and HLA genotypes among individuals also influences the efficacy of NK-cell-mediated immunosurveillance, and certain KIR-HLA mismatches are being exploited in hematopoietic stem cell transplantation to improve graft-versus-leukemia effects. Here, KIR3DL1 is linked to leukemia.